PathChat, a new large language model (LLM) specifically designed for pathology, has demonstrated remarkable accuracy in diagnosing tumors and other serious conditions. In a recent study, PathChat outperformed leading models such as ChatGPT-4, LLaVA, and LLaVA-Med in identifying the location, origin, and extent of tumors from medical images. The model’s ability to understand pathology images and clinically relevant text, and engage in conversations with pathologists, makes it a significant breakthrough in computational pathology. PathChat’s creators envision it as a consultant for human pathologists, assisting in diagnosis and research. This technology has far-reaching implications for improving healthcare outcomes, particularly in low-resource settings where access to experienced pathologists is limited.
AI-powered PathChat beats leading models in diagnostic accuracy
PathChat represents a breakthrough in computational pathology, serving as a consultant for human pathologists to help identify, assess, and diagnose tumors and other serious conditions.
1–2 minutes
TOP STORIES
Maine’s new bill pauses large data center construction to assess environmental impacts …
Authorities arrested Daniel Moreno-Gama for attacking OpenAI CEO Sam Altman over his fears about AI …
Anthropic’s Mythos model raises national security concerns while sparking a lawsuit against the DOD …
USDA’s decision to implement the controversial Grok chatbot marks a significant shift in government AI adoption …
Sam Altman reflects on a recent attack and the impact of narratives on his leadership …
A Silicon Valley entrepreneur’s obsession with ChatGPT leads to a harassment lawsuit against OpenAI …
